More Answers for More Patients
A Multi-Analyte Algorithmic Blood Test to Aid in the Diagnostic Evaluation for Alzheimer’s Disease
LucentAD Complete
LucentADTM Complete is a best-in-class, multi-marker blood test for patients being evaluated for Alzheimer’s Disease. Lucent Diagnostics’ novel approach analyzes 5 unique biomarkers, (p-Tau 217, Aβ42/40, NfL, GFAP1) with an algorithmic score to indicate probability of amyloid pathology, in one blood test.
Precision & Performance
With a multi-analyte algorithmic test, the precision of the logistic risk score is dependent upon the precision of all the assays in the test. LucentAD Complete measures five different analytes. The precision of four of the five tests (Ab40, Ab42, GFAP, and NfL) is largely dictated by the precision of a single multiplexed immunoassay in which all assays are performed simultaneously, thus reducing the variability of four different immunoassays. This consolidation of multiple tests into a single assay benefits the overall precision of the algorithm.
The LucentAD Complete test is run in Lucent Diagnostics CLIA certified laboratory and is available in the US to medical providers, for their eligible patients. Blood samples are shipped, refrigerated or frozen, to the Lucent laboratory in packaging provided. The company plans to announce additional tests, aimed at improving the diagnosis and management of AD and other neurological disorders.
Patient & Caregiver Empowerment
Patient empowerment lies at the core of our mission. We understand the anxiety and uncertainty that Alzheimer’s Disease can bring to both patients and caregivers. Lucent Diagnostics is passionate about making a difference in the lives of patients and their families. We are committed to providing you with the knowledge and tools you need to make the most informed decisions about your health.
Affordable Testing
LucentAD Complete is intended for patients with mild cognitive impairment and/or who are undergoing cognitive evaluation. This test is new and is not currently covered by commercial insurance, Medicare or Medicaid. Lucent Diagnostics is currently pursing payer coverage. In the meantime, we will work with patients to provide testing within their financial means. Consult your healthcare provider to see if LucentAD Complete is right for you or your loved one.
Take Action
Learn more about LucentAD Complete
Click on the LucentAD Complete White Paper button to learn more about the revolutionary blood test.
Step 1
A healthcare provider orders LucentAD Complete blood test and schedules a blood draw appointment.
Step 2
Blood samples are sent to the Lucent Diagnostics laboratory for analysis.
Step 3
Healthcare providers receive test reports and discusses the results with their patients.
Learn More
Looking for more information? Please contact the Lucent Diagnostics Customer Service Team at 978.488.1869 or email customerservice@lucentdiagnostics.com
Contact Us to Order a Test
Disclaimers
GFAP is offered pursuant to a license from Banyan Biomarkers, Inc. Banyan GFAP® is a registered trademark of Banyan Biomarkers.
The Lucent Diagnostics’ tests have been developed and validated by Quanterix Corporation (CLIA# 22D1053083) in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.
Disclaimer
The information provided on this website is for educational purposes only and should not be considered as medical advice. Please consult with your healthcare provider for personalized guidance and treatment options.